Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients
Abstract Background Repetitive transcranial magnetic stimulation (TMS) has been shown to be safe and effective for treatment-resistant depression (TRD) in the general adult population. Efficacy among older (≥60 years) patients, who have a greater burden of cognitive, physical, and functional impairm...
Gespeichert in:
| Veröffentlicht in: | Journal of affective disorders 2017-08, Vol.217, p.42-47 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 47 |
|---|---|
| container_issue | |
| container_start_page | 42 |
| container_title | Journal of affective disorders |
| container_volume | 217 |
| creator | Conelea, Christine A Philip, Noah S Yip, Agustin G Barnes, Jennifer L Niedzwiecki, Matthew J Greenberg, Benjamin D Tyrka, Audrey R Carpenter, Linda L |
| description | Abstract Background Repetitive transcranial magnetic stimulation (TMS) has been shown to be safe and effective for treatment-resistant depression (TRD) in the general adult population. Efficacy among older (≥60 years) patients, who have a greater burden of cognitive, physical, and functional impairment compared to their younger counterparts, remains unclear. The current study aimed to characterize antidepressant response to an acute course of TMS therapy among patients aged ≥60 years compared to those |
| doi_str_mv | 10.1016/j.jad.2017.03.063 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5460629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0165032716319814</els_id><sourcerecordid>1885945288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c572t-a355386f774c7aa93e9fb647249947ff65a6e2070f15156a080374d1e6cd7ec33</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhS0EokPhAdigLNkk2PFvQKpUlV-pMIgOC1aW69wMHhJ7sJ2R-gS8Nh6mjIAFG1vW_c65V_cYoccENwQT8WzTbEzftJjIBtMGC3oHLQiXtG45kXfRojC8xrSVJ-hBShuMsegkvo9OWkWVYoIt0I9VND7ZcjgzVu_N2kN2trrKbppHk13w1RBitYpg8gQ-158guZSNz9VL2EZIqSDPqw8mz9GMpVLER7haztmGCdIvjy9h9muI1Q5imlO1HPvy-Fh6FDI9RPcGMyZ4dHufos-vX60u3taXyzfvLs4va8tlm2tDOadKDFIyK43pKHTDtWCyZV3H5DAIbgS0WOKBcMKFwQpTyXoCwvYSLKWn6Ozgu52vJ-ht6V3m1tvoJhNvdDBO_13x7qteh53mTGDRdsXg6a1BDN9nSFlPLlkYR-MhzEkTpXjHeKtUQckBtTGkFGE4tiFY7wPUG10C1PsANaa6BFg0T_6c76j4nVgBXhwAKFvaOYg62bJBC72LYLPug_uv_dk_ajs676wZv8ENpE2Yoy_r10SnVmN9tf9B-w9EBCWdIoz-BKIPxH0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1885945288</pqid></control><display><type>article</type><title>Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Conelea, Christine A ; Philip, Noah S ; Yip, Agustin G ; Barnes, Jennifer L ; Niedzwiecki, Matthew J ; Greenberg, Benjamin D ; Tyrka, Audrey R ; Carpenter, Linda L</creator><creatorcontrib>Conelea, Christine A ; Philip, Noah S ; Yip, Agustin G ; Barnes, Jennifer L ; Niedzwiecki, Matthew J ; Greenberg, Benjamin D ; Tyrka, Audrey R ; Carpenter, Linda L</creatorcontrib><description>Abstract Background Repetitive transcranial magnetic stimulation (TMS) has been shown to be safe and effective for treatment-resistant depression (TRD) in the general adult population. Efficacy among older (≥60 years) patients, who have a greater burden of cognitive, physical, and functional impairment compared to their younger counterparts, remains unclear. The current study aimed to characterize antidepressant response to an acute course of TMS therapy among patients aged ≥60 years compared to those <60 years in naturalistic clinical practice settings. Methods Data were retrospectively collected and pooled for adults with TRD (N = 231; n = 75 aged ≥60 years and n = 156 <60 years) who underwent an acute course of outpatient TMS therapy at two outpatient clinics. Self-report depression scales were administered at baseline and end of acute treatment. Change on continuous measures and categorical outcomes were compared across older vs. younger patients. Results Both age groups showed significant improvements in depression symptoms. Response and remission rates did not differ between groups. Age group was not a significant predictor of change in depression severity, nor of clinical response or remission, in a model controlling for other predictors (all p >.05). Limitations Limitations include reliance on self-report clinical measures and variability in comorbidity and concurrent pharmacotherapy due to the naturalistic nature of the study. Conclusions Results suggest that effectiveness of TMS for TRD is not differentially modified by age. Based on these naturalistic data, age alone should not be considered a contraindication or poor prognostic indicator of the antidepressant efficacy of TMS.</description><identifier>ISSN: 0165-0327</identifier><identifier>ISSN: 1573-2517</identifier><identifier>EISSN: 1573-2517</identifier><identifier>DOI: 10.1016/j.jad.2017.03.063</identifier><identifier>PMID: 28388464</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Aging - psychology ; Depression ; Depressive Disorder, Treatment-Resistant - therapy ; Female ; Geriatric ; Humans ; Male ; Middle Aged ; Psychiatric Status Rating Scales ; Psychiatry ; Retrospective Studies ; Self Report ; TMS ; Transcranial Magnetic Stimulation ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of affective disorders, 2017-08, Vol.217, p.42-47</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c572t-a355386f774c7aa93e9fb647249947ff65a6e2070f15156a080374d1e6cd7ec33</citedby><cites>FETCH-LOGICAL-c572t-a355386f774c7aa93e9fb647249947ff65a6e2070f15156a080374d1e6cd7ec33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165032716319814$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28388464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conelea, Christine A</creatorcontrib><creatorcontrib>Philip, Noah S</creatorcontrib><creatorcontrib>Yip, Agustin G</creatorcontrib><creatorcontrib>Barnes, Jennifer L</creatorcontrib><creatorcontrib>Niedzwiecki, Matthew J</creatorcontrib><creatorcontrib>Greenberg, Benjamin D</creatorcontrib><creatorcontrib>Tyrka, Audrey R</creatorcontrib><creatorcontrib>Carpenter, Linda L</creatorcontrib><title>Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients</title><title>Journal of affective disorders</title><addtitle>J Affect Disord</addtitle><description>Abstract Background Repetitive transcranial magnetic stimulation (TMS) has been shown to be safe and effective for treatment-resistant depression (TRD) in the general adult population. Efficacy among older (≥60 years) patients, who have a greater burden of cognitive, physical, and functional impairment compared to their younger counterparts, remains unclear. The current study aimed to characterize antidepressant response to an acute course of TMS therapy among patients aged ≥60 years compared to those <60 years in naturalistic clinical practice settings. Methods Data were retrospectively collected and pooled for adults with TRD (N = 231; n = 75 aged ≥60 years and n = 156 <60 years) who underwent an acute course of outpatient TMS therapy at two outpatient clinics. Self-report depression scales were administered at baseline and end of acute treatment. Change on continuous measures and categorical outcomes were compared across older vs. younger patients. Results Both age groups showed significant improvements in depression symptoms. Response and remission rates did not differ between groups. Age group was not a significant predictor of change in depression severity, nor of clinical response or remission, in a model controlling for other predictors (all p >.05). Limitations Limitations include reliance on self-report clinical measures and variability in comorbidity and concurrent pharmacotherapy due to the naturalistic nature of the study. Conclusions Results suggest that effectiveness of TMS for TRD is not differentially modified by age. Based on these naturalistic data, age alone should not be considered a contraindication or poor prognostic indicator of the antidepressant efficacy of TMS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - psychology</subject><subject>Depression</subject><subject>Depressive Disorder, Treatment-Resistant - therapy</subject><subject>Female</subject><subject>Geriatric</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Retrospective Studies</subject><subject>Self Report</subject><subject>TMS</subject><subject>Transcranial Magnetic Stimulation</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0165-0327</issn><issn>1573-2517</issn><issn>1573-2517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks1u1DAUhS0EokPhAdigLNkk2PFvQKpUlV-pMIgOC1aW69wMHhJ7sJ2R-gS8Nh6mjIAFG1vW_c65V_cYoccENwQT8WzTbEzftJjIBtMGC3oHLQiXtG45kXfRojC8xrSVJ-hBShuMsegkvo9OWkWVYoIt0I9VND7ZcjgzVu_N2kN2trrKbppHk13w1RBitYpg8gQ-158guZSNz9VL2EZIqSDPqw8mz9GMpVLER7haztmGCdIvjy9h9muI1Q5imlO1HPvy-Fh6FDI9RPcGMyZ4dHufos-vX60u3taXyzfvLs4va8tlm2tDOadKDFIyK43pKHTDtWCyZV3H5DAIbgS0WOKBcMKFwQpTyXoCwvYSLKWn6Ozgu52vJ-ht6V3m1tvoJhNvdDBO_13x7qteh53mTGDRdsXg6a1BDN9nSFlPLlkYR-MhzEkTpXjHeKtUQckBtTGkFGE4tiFY7wPUG10C1PsANaa6BFg0T_6c76j4nVgBXhwAKFvaOYg62bJBC72LYLPug_uv_dk_ajs676wZv8ENpE2Yoy_r10SnVmN9tf9B-w9EBCWdIoz-BKIPxH0</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Conelea, Christine A</creator><creator>Philip, Noah S</creator><creator>Yip, Agustin G</creator><creator>Barnes, Jennifer L</creator><creator>Niedzwiecki, Matthew J</creator><creator>Greenberg, Benjamin D</creator><creator>Tyrka, Audrey R</creator><creator>Carpenter, Linda L</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170801</creationdate><title>Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients</title><author>Conelea, Christine A ; Philip, Noah S ; Yip, Agustin G ; Barnes, Jennifer L ; Niedzwiecki, Matthew J ; Greenberg, Benjamin D ; Tyrka, Audrey R ; Carpenter, Linda L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c572t-a355386f774c7aa93e9fb647249947ff65a6e2070f15156a080374d1e6cd7ec33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - psychology</topic><topic>Depression</topic><topic>Depressive Disorder, Treatment-Resistant - therapy</topic><topic>Female</topic><topic>Geriatric</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Retrospective Studies</topic><topic>Self Report</topic><topic>TMS</topic><topic>Transcranial Magnetic Stimulation</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conelea, Christine A</creatorcontrib><creatorcontrib>Philip, Noah S</creatorcontrib><creatorcontrib>Yip, Agustin G</creatorcontrib><creatorcontrib>Barnes, Jennifer L</creatorcontrib><creatorcontrib>Niedzwiecki, Matthew J</creatorcontrib><creatorcontrib>Greenberg, Benjamin D</creatorcontrib><creatorcontrib>Tyrka, Audrey R</creatorcontrib><creatorcontrib>Carpenter, Linda L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of affective disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conelea, Christine A</au><au>Philip, Noah S</au><au>Yip, Agustin G</au><au>Barnes, Jennifer L</au><au>Niedzwiecki, Matthew J</au><au>Greenberg, Benjamin D</au><au>Tyrka, Audrey R</au><au>Carpenter, Linda L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients</atitle><jtitle>Journal of affective disorders</jtitle><addtitle>J Affect Disord</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>217</volume><spage>42</spage><epage>47</epage><pages>42-47</pages><issn>0165-0327</issn><issn>1573-2517</issn><eissn>1573-2517</eissn><abstract>Abstract Background Repetitive transcranial magnetic stimulation (TMS) has been shown to be safe and effective for treatment-resistant depression (TRD) in the general adult population. Efficacy among older (≥60 years) patients, who have a greater burden of cognitive, physical, and functional impairment compared to their younger counterparts, remains unclear. The current study aimed to characterize antidepressant response to an acute course of TMS therapy among patients aged ≥60 years compared to those <60 years in naturalistic clinical practice settings. Methods Data were retrospectively collected and pooled for adults with TRD (N = 231; n = 75 aged ≥60 years and n = 156 <60 years) who underwent an acute course of outpatient TMS therapy at two outpatient clinics. Self-report depression scales were administered at baseline and end of acute treatment. Change on continuous measures and categorical outcomes were compared across older vs. younger patients. Results Both age groups showed significant improvements in depression symptoms. Response and remission rates did not differ between groups. Age group was not a significant predictor of change in depression severity, nor of clinical response or remission, in a model controlling for other predictors (all p >.05). Limitations Limitations include reliance on self-report clinical measures and variability in comorbidity and concurrent pharmacotherapy due to the naturalistic nature of the study. Conclusions Results suggest that effectiveness of TMS for TRD is not differentially modified by age. Based on these naturalistic data, age alone should not be considered a contraindication or poor prognostic indicator of the antidepressant efficacy of TMS.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28388464</pmid><doi>10.1016/j.jad.2017.03.063</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0165-0327 |
| ispartof | Journal of affective disorders, 2017-08, Vol.217, p.42-47 |
| issn | 0165-0327 1573-2517 1573-2517 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5460629 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adolescent Adult Aged Aged, 80 and over Aging - psychology Depression Depressive Disorder, Treatment-Resistant - therapy Female Geriatric Humans Male Middle Aged Psychiatric Status Rating Scales Psychiatry Retrospective Studies Self Report TMS Transcranial Magnetic Stimulation Treatment Outcome Young Adult |
| title | Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Naturalistic Treatment Outcomes for Younger versus Older Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A03%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcranial%20Magnetic%20Stimulation%20for%20Treatment-Resistant%20Depression:%20Naturalistic%20Treatment%20Outcomes%20for%20Younger%20versus%20Older%20Patients&rft.jtitle=Journal%20of%20affective%20disorders&rft.au=Conelea,%20Christine%20A&rft.date=2017-08-01&rft.volume=217&rft.spage=42&rft.epage=47&rft.pages=42-47&rft.issn=0165-0327&rft.eissn=1573-2517&rft_id=info:doi/10.1016/j.jad.2017.03.063&rft_dat=%3Cproquest_pubme%3E1885945288%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1885945288&rft_id=info:pmid/28388464&rft_els_id=1_s2_0_S0165032716319814&rfr_iscdi=true |